Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
KLF8
|
ENSG00000102349.10 | Kruppel like factor 8 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
KLF8 | hg19_v2_chrX_+_56258844_56258882 | 0.12 | 5.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22712087 | 8.11 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr22_+_22735135 | 6.98 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr14_-_106114739 | 5.31 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr22_+_22764088 | 5.16 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
chr22_+_22676808 | 4.84 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
chr22_+_22385332 | 4.42 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr22_+_22681656 | 4.04 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr22_+_22786288 | 3.71 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr14_-_106209368 | 3.49 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chr22_+_23089870 | 3.45 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr14_-_106312010 | 3.33 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
chr22_+_23054174 | 3.33 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
chr14_-_106725723 | 3.22 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr2_-_89310012 | 3.20 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr22_+_22730353 | 3.09 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr2_+_90139056 | 3.03 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_+_23114284 | 2.98 |
ENST00000390313.2
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr21_-_46330545 | 2.89 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr22_+_23161491 | 2.85 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
chr14_-_106878083 | 2.85 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr19_+_55795493 | 2.85 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr22_+_23222886 | 2.85 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr1_+_26644441 | 2.79 |
ENST00000374213.2
|
CD52
|
CD52 molecule |
chr19_+_1067271 | 2.70 |
ENST00000536472.1
ENST00000590214.1 |
HMHA1
|
histocompatibility (minor) HA-1 |
chr11_-_64511789 | 2.53 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr14_-_106406090 | 2.51 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr14_-_106092403 | 2.46 |
ENST00000390543.2
|
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr22_+_23063100 | 2.46 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr22_+_23248512 | 2.40 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
chr16_+_222846 | 2.39 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr2_-_89266286 | 2.34 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr17_-_80275417 | 2.30 |
ENST00000583376.1
ENST00000578509.1 ENST00000584284.1 ENST00000582480.1 |
CD7
|
CD7 molecule |
chr15_-_31521567 | 2.29 |
ENST00000560812.1
ENST00000559853.1 ENST00000558109.1 |
RP11-16E12.2
|
RP11-16E12.2 |
chr16_+_32077386 | 2.27 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr22_+_23264766 | 2.27 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr21_-_47613673 | 2.24 |
ENST00000594486.1
|
AP001468.1
|
Protein LOC101060037 |
chr22_+_37309662 | 2.24 |
ENST00000403662.3
ENST00000262825.5 |
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
chr2_+_90229045 | 2.23 |
ENST00000390278.2
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr22_+_23229960 | 2.16 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr14_-_106330458 | 2.16 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr22_+_23154239 | 2.09 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
chr1_-_25291475 | 2.05 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
chr1_-_111217603 | 2.04 |
ENST00000369769.2
|
KCNA3
|
potassium voltage-gated channel, shaker-related subfamily, member 3 |
chr16_+_32063311 | 2.04 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
chr22_+_23040274 | 2.03 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr14_+_105559784 | 2.03 |
ENST00000548104.1
|
RP11-44N21.1
|
RP11-44N21.1 |
chr14_-_106322288 | 1.99 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr9_-_37034028 | 1.96 |
ENST00000520281.1
ENST00000446742.1 ENST00000522003.1 ENST00000523145.1 ENST00000414447.1 ENST00000377847.2 ENST00000377853.2 ENST00000377852.2 ENST00000523241.1 ENST00000520154.1 ENST00000358127.4 |
PAX5
|
paired box 5 |
chr2_-_89568263 | 1.90 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
chr14_-_106781017 | 1.90 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr16_+_23847339 | 1.86 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr22_+_51112800 | 1.85 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr20_-_1165117 | 1.85 |
ENST00000381894.3
|
TMEM74B
|
transmembrane protein 74B |
chr14_-_106330072 | 1.84 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
chr15_+_29211570 | 1.84 |
ENST00000558804.1
|
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr14_-_106586656 | 1.82 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr15_-_44969086 | 1.82 |
ENST00000434130.1
ENST00000560780.1 |
PATL2
|
protein associated with topoisomerase II homolog 2 (yeast) |
chr14_-_107035208 | 1.81 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr14_-_106668095 | 1.81 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
chr19_-_3786253 | 1.81 |
ENST00000585778.1
|
MATK
|
megakaryocyte-associated tyrosine kinase |
chr14_-_106054659 | 1.81 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr14_-_106518922 | 1.79 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
chr19_-_51875894 | 1.78 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr20_+_30639991 | 1.78 |
ENST00000534862.1
ENST00000538448.1 ENST00000375862.2 |
HCK
|
hemopoietic cell kinase |
chr14_-_107219365 | 1.75 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr20_+_30640004 | 1.73 |
ENST00000520553.1
ENST00000518730.1 ENST00000375852.2 |
HCK
|
hemopoietic cell kinase |
chr1_-_1142067 | 1.72 |
ENST00000379268.2
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr22_+_23237555 | 1.71 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 (Mcg marker) |
chr22_+_23165153 | 1.71 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr14_-_106174960 | 1.70 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr16_+_28943260 | 1.70 |
ENST00000538922.1
ENST00000324662.3 ENST00000567541.1 |
CD19
|
CD19 molecule |
chr17_+_34430980 | 1.69 |
ENST00000250151.4
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr6_+_31865552 | 1.69 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr16_+_56995854 | 1.68 |
ENST00000566128.1
|
CETP
|
cholesteryl ester transfer protein, plasma |
chr14_-_106692191 | 1.67 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr1_-_160681593 | 1.67 |
ENST00000368045.3
ENST00000368046.3 |
CD48
|
CD48 molecule |
chr15_+_77308152 | 1.64 |
ENST00000559859.1
|
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr17_-_61777459 | 1.64 |
ENST00000578993.1
ENST00000583211.1 ENST00000259006.3 |
LIMD2
|
LIM domain containing 2 |
chr14_-_106791536 | 1.63 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr14_-_96180435 | 1.63 |
ENST00000556450.1
ENST00000555202.1 ENST00000554012.1 ENST00000402399.1 |
TCL1A
|
T-cell leukemia/lymphoma 1A |
chr16_+_27413483 | 1.62 |
ENST00000337929.3
ENST00000564089.1 |
IL21R
|
interleukin 21 receptor |
chr14_-_107078851 | 1.60 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr14_-_106994333 | 1.60 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr22_+_23247030 | 1.59 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr19_-_7766991 | 1.57 |
ENST00000597921.1
ENST00000346664.5 |
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr16_+_56995762 | 1.57 |
ENST00000200676.3
ENST00000379780.2 |
CETP
|
cholesteryl ester transfer protein, plasma |
chr9_-_124976154 | 1.56 |
ENST00000482062.1
|
LHX6
|
LIM homeobox 6 |
chr19_-_3786354 | 1.56 |
ENST00000395040.2
ENST00000310132.6 |
MATK
|
megakaryocyte-associated tyrosine kinase |
chr22_+_23243156 | 1.56 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
chr1_+_27668505 | 1.54 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
chr14_-_106733624 | 1.54 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr22_+_50986462 | 1.53 |
ENST00000395676.2
|
KLHDC7B
|
kelch domain containing 7B |
chr22_+_22930626 | 1.53 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr22_+_23029188 | 1.52 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr11_-_64512273 | 1.51 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr14_-_107013465 | 1.51 |
ENST00000390625.2
|
IGHV3-49
|
immunoglobulin heavy variable 3-49 |
chr11_+_67171548 | 1.51 |
ENST00000542590.1
|
TBC1D10C
|
TBC1 domain family, member 10C |
chr20_+_37554955 | 1.49 |
ENST00000217429.4
|
FAM83D
|
family with sequence similarity 83, member D |
chr14_-_106478603 | 1.48 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr12_-_109027643 | 1.47 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr14_-_106845789 | 1.45 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
chr2_-_197036289 | 1.45 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr14_-_106330824 | 1.45 |
ENST00000463911.1
|
IGHJ3
|
immunoglobulin heavy joining 3 |
chr17_-_80275466 | 1.45 |
ENST00000312648.3
|
CD7
|
CD7 molecule |
chr1_-_207096529 | 1.44 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr12_+_49297899 | 1.44 |
ENST00000552942.1
ENST00000320516.4 |
CCDC65
|
coiled-coil domain containing 65 |
chr11_+_1897697 | 1.44 |
ENST00000432093.1
|
LSP1
|
lymphocyte-specific protein 1 |
chr1_-_25256368 | 1.44 |
ENST00000308873.6
|
RUNX3
|
runt-related transcription factor 3 |
chr14_-_107083690 | 1.43 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr11_-_64512469 | 1.42 |
ENST00000377485.1
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr22_-_37882395 | 1.42 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr4_-_819880 | 1.41 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
chr14_-_107095662 | 1.41 |
ENST00000390630.2
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
chr14_+_106355918 | 1.39 |
ENST00000414005.1
|
AL122127.25
|
AL122127.25 |
chr20_-_4804244 | 1.39 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr2_-_89247338 | 1.39 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr10_-_135150367 | 1.38 |
ENST00000368555.3
ENST00000252939.4 ENST00000368558.1 ENST00000368556.2 |
CALY
|
calcyon neuron-specific vesicular protein |
chr16_+_33020496 | 1.38 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
chr17_-_31404 | 1.37 |
ENST00000343572.7
|
DOC2B
|
double C2-like domains, beta |
chr19_+_35606692 | 1.36 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr20_+_44637526 | 1.35 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr7_-_142181009 | 1.35 |
ENST00000390368.2
|
TRBV6-5
|
T cell receptor beta variable 6-5 |
chr17_-_54893250 | 1.34 |
ENST00000397862.2
|
C17orf67
|
chromosome 17 open reading frame 67 |
chr16_+_226658 | 1.34 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr3_-_71834318 | 1.32 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
chr10_-_135090338 | 1.32 |
ENST00000415217.3
|
ADAM8
|
ADAM metallopeptidase domain 8 |
chr19_-_49945617 | 1.32 |
ENST00000600601.1
ENST00000543531.1 |
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr1_-_31230650 | 1.31 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr7_+_142494525 | 1.31 |
ENST00000390415.1
|
TRBJ2-3
|
T cell receptor beta joining 2-3 |
chr19_-_44172467 | 1.30 |
ENST00000599892.1
|
PLAUR
|
plasminogen activator, urokinase receptor |
chr11_-_64510409 | 1.30 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr13_+_43148281 | 1.30 |
ENST00000239849.6
ENST00000398795.2 ENST00000544862.1 |
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11 |
chr19_+_35634146 | 1.30 |
ENST00000586063.1
ENST00000270310.2 ENST00000588265.1 |
FXYD7
|
FXYD domain containing ion transport regulator 7 |
chr14_-_106805716 | 1.30 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr19_-_54850417 | 1.27 |
ENST00000291759.4
|
LILRA4
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 |
chr9_-_136344237 | 1.27 |
ENST00000432868.1
ENST00000371899.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr2_+_89901292 | 1.27 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr12_+_4918342 | 1.27 |
ENST00000280684.3
ENST00000433855.1 |
KCNA6
|
potassium voltage-gated channel, shaker-related subfamily, member 6 |
chr22_+_22697537 | 1.27 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr1_-_1141927 | 1.26 |
ENST00000328596.6
ENST00000379265.5 |
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18 |
chr20_+_42295745 | 1.26 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
chr1_+_16767195 | 1.26 |
ENST00000504551.2
ENST00000457722.2 ENST00000406746.1 ENST00000443980.2 |
NECAP2
|
NECAP endocytosis associated 2 |
chr20_+_31870927 | 1.26 |
ENST00000253354.1
|
BPIFB1
|
BPI fold containing family B, member 1 |
chr9_-_117111222 | 1.26 |
ENST00000374079.4
|
AKNA
|
AT-hook transcription factor |
chr16_+_58535372 | 1.25 |
ENST00000566656.1
ENST00000566618.1 |
NDRG4
|
NDRG family member 4 |
chr4_-_819901 | 1.25 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
chr15_-_20193370 | 1.25 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr17_+_7788104 | 1.25 |
ENST00000380358.4
|
CHD3
|
chromodomain helicase DNA binding protein 3 |
chr22_+_22550113 | 1.24 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
chr2_-_89597542 | 1.24 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr7_+_50344289 | 1.24 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr19_-_10024496 | 1.24 |
ENST00000593091.1
|
OLFM2
|
olfactomedin 2 |
chr5_-_157002775 | 1.24 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr21_-_46348694 | 1.23 |
ENST00000355153.4
ENST00000397850.2 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr17_-_45056606 | 1.22 |
ENST00000322329.3
|
RPRML
|
reprimo-like |
chr22_+_24820341 | 1.22 |
ENST00000464977.1
ENST00000444262.2 |
ADORA2A
|
adenosine A2a receptor |
chr10_-_81320151 | 1.21 |
ENST00000372325.2
ENST00000372327.5 ENST00000417041.1 |
SFTPA2
|
surfactant protein A2 |
chr16_+_1291240 | 1.20 |
ENST00000561736.1
|
TPSAB1
|
tryptase alpha/beta 1 |
chr6_-_31560729 | 1.20 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr9_-_113800705 | 1.19 |
ENST00000441240.1
|
LPAR1
|
lysophosphatidic acid receptor 1 |
chr4_-_165305086 | 1.19 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr2_+_89986318 | 1.19 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr1_+_26348259 | 1.18 |
ENST00000374280.3
|
EXTL1
|
exostosin-like glycosyltransferase 1 |
chr2_+_90198535 | 1.18 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr14_-_50506589 | 1.17 |
ENST00000553914.2
|
RP11-58E21.3
|
RP11-58E21.3 |
chr22_+_23235872 | 1.17 |
ENST00000390320.2
|
IGLJ1
|
immunoglobulin lambda joining 1 |
chr2_-_136873735 | 1.17 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr19_+_51645556 | 1.17 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
chr14_-_107211459 | 1.16 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr2_+_182322070 | 1.16 |
ENST00000233573.6
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr19_-_54784353 | 1.16 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr17_-_61777090 | 1.16 |
ENST00000578061.1
|
LIMD2
|
LIM domain containing 2 |
chr19_+_1071203 | 1.16 |
ENST00000543365.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr14_-_106830057 | 1.16 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr11_+_60869867 | 1.16 |
ENST00000347785.3
|
CD5
|
CD5 molecule |
chr13_-_114898016 | 1.16 |
ENST00000542651.1
ENST00000334062.7 |
RASA3
|
RAS p21 protein activator 3 |
chr1_+_207277590 | 1.15 |
ENST00000367070.3
|
C4BPA
|
complement component 4 binding protein, alpha |
chr5_+_118604439 | 1.15 |
ENST00000388882.5
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
chr19_+_35773242 | 1.14 |
ENST00000222304.3
|
HAMP
|
hepcidin antimicrobial peptide |
chr22_-_42322795 | 1.14 |
ENST00000291232.3
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C |
chr15_+_81591757 | 1.14 |
ENST00000558332.1
|
IL16
|
interleukin 16 |
chr9_-_136344197 | 1.14 |
ENST00000414172.1
ENST00000371897.4 |
SLC2A6
|
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr7_+_121513374 | 1.14 |
ENST00000449182.1
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1 |
chr19_-_8642289 | 1.14 |
ENST00000596675.1
ENST00000338257.8 |
MYO1F
|
myosin IF |
chr5_+_133477905 | 1.13 |
ENST00000517799.1
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box) |
chr11_+_113848216 | 1.13 |
ENST00000299961.5
|
HTR3A
|
5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
chr19_+_17638059 | 1.13 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
chr4_+_156824840 | 1.13 |
ENST00000536354.2
|
TDO2
|
tryptophan 2,3-dioxygenase |
chr7_-_38389573 | 1.13 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
chr15_-_44969022 | 1.13 |
ENST00000560110.1
|
PATL2
|
protein associated with topoisomerase II homolog 2 (yeast) |
chr17_-_42277203 | 1.13 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr22_+_22516550 | 1.12 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr11_-_64511575 | 1.12 |
ENST00000431822.1
ENST00000377486.3 ENST00000394432.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr1_-_202130702 | 1.12 |
ENST00000309017.3
ENST00000477554.1 ENST00000492451.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr19_+_42259329 | 1.12 |
ENST00000199764.6
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
chr2_+_90153696 | 1.12 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr2_+_97779233 | 1.11 |
ENST00000461153.2
ENST00000420699.2 |
ANKRD36
|
ankyrin repeat domain 36 |
chr9_-_4679419 | 1.11 |
ENST00000609131.1
ENST00000607997.1 |
RP11-6J24.6
|
RP11-6J24.6 |
chr9_-_124976185 | 1.11 |
ENST00000464484.2
|
LHX6
|
LIM homeobox 6 |
chr10_+_102106829 | 1.10 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.8 | 2.5 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.8 | 4.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.8 | 2.3 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
0.7 | 2.9 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.7 | 125.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.7 | 3.5 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.7 | 2.7 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 0.7 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.6 | 1.9 | GO:0100009 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.6 | 1.8 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.6 | 1.7 | GO:0048627 | myoblast development(GO:0048627) |
0.5 | 1.1 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.5 | 0.5 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.5 | 0.5 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.5 | 2.9 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.5 | 2.4 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.5 | 1.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.5 | 3.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 1.4 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.5 | 1.4 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.4 | 2.7 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
0.4 | 1.8 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.4 | 1.3 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.4 | 1.3 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.4 | 1.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 1.7 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.4 | 0.4 | GO:0070372 | regulation of ERK1 and ERK2 cascade(GO:0070372) |
0.4 | 1.2 | GO:0071529 | cementum mineralization(GO:0071529) |
0.4 | 2.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.4 | 1.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.4 | 2.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.4 | 0.4 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.4 | 2.7 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.4 | 1.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.4 | 0.4 | GO:0002519 | natural killer cell tolerance induction(GO:0002519) |
0.4 | 0.4 | GO:0042756 | drinking behavior(GO:0042756) |
0.4 | 0.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.4 | 1.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.4 | 0.4 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.4 | 2.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 1.1 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.4 | 1.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 1.8 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 1.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 1.4 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.4 | 1.4 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.4 | 1.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 1.7 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.3 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 2.3 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.3 | 1.0 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.3 | 1.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 0.3 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.3 | 0.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 5.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 0.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.3 | 0.9 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.3 | 0.3 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.3 | 3.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 2.4 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.3 | 0.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 1.8 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 0.3 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
0.3 | 0.9 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.3 | 1.4 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.3 | 0.3 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.3 | 1.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.9 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.3 | 0.6 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.3 | 5.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.8 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.3 | 1.1 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.3 | 0.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.8 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 2.1 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.3 | 0.3 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.3 | 1.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.3 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.2 | 1.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 2.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.2 | 0.7 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.2 | 0.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.2 | 0.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.7 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 3.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.2 | 0.7 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.2 | 0.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 1.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.2 | GO:0060290 | transdifferentiation(GO:0060290) |
0.2 | 4.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.7 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.2 | 7.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 1.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 0.7 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.2 | 3.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 1.1 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 0.4 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 3.8 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.2 | 3.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 0.9 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 2.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 0.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 45.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 1.1 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 | 1.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 0.2 | GO:0048387 | regulation of retinoic acid receptor signaling pathway(GO:0048385) negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 0.8 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.2 | 1.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 0.6 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.2 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 1.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.8 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.2 | 1.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.2 | 1.6 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.2 | 0.4 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
0.2 | 1.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.2 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.2 | 1.8 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 1.0 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) dGDP metabolic process(GO:0046066) |
0.2 | 3.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 2.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.7 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.2 | 0.6 | GO:1904247 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.2 | 0.7 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.2 | 0.5 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.2 | 0.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.2 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 1.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.2 | 2.0 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.7 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.2 | 0.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 0.9 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.2 | 1.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 1.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 1.0 | GO:0030421 | defecation(GO:0030421) |
0.2 | 0.7 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.2 | 1.4 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 2.7 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.2 | 1.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.2 | 2.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.2 | 0.5 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
0.2 | 1.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 1.0 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.2 | 0.5 | GO:0003192 | mitral valve formation(GO:0003192) |
0.2 | 4.9 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 0.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 | 1.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.3 | GO:0009189 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.2 | 0.5 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.2 | 0.3 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
0.2 | 0.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.2 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 2.4 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.6 | GO:0090346 | alkaloid catabolic process(GO:0009822) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 0.6 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 0.2 | GO:0007497 | posterior midgut development(GO:0007497) |
0.2 | 0.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 0.3 | GO:0060066 | oviduct development(GO:0060066) |
0.2 | 0.5 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) |
0.2 | 0.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.2 | 0.5 | GO:1904172 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.1 | 0.6 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.1 | 0.3 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.1 | 2.5 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 2.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.1 | 1.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 1.2 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 0.7 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.1 | 1.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 1.0 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.7 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 1.7 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.4 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.1 | 0.4 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.6 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 3.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.4 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.1 | 0.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 2.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.8 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 1.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 1.9 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 1.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.4 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 1.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.1 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 1.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 2.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.5 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 2.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 1.2 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.4 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.1 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 1.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.5 | GO:0035711 | plasmacytoid dendritic cell activation(GO:0002270) T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) regulation of restriction endodeoxyribonuclease activity(GO:0032072) T-helper 1 cell activation(GO:0035711) negative regulation of apoptotic cell clearance(GO:2000426) |
0.1 | 1.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.1 | 0.1 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.1 | 0.6 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 1.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 1.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 1.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.5 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.1 | 0.7 | GO:0098759 | interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 1.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.4 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 0.5 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.1 | 2.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 2.6 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.6 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 3.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.1 | 0.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 0.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.9 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
0.1 | 0.1 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
0.1 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.1 | 0.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 1.7 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
0.1 | 0.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.2 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.2 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.1 | 0.9 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 4.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.4 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.9 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 1.6 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.1 | 1.6 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.1 | 0.8 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.1 | 0.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.1 | 0.3 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.8 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.1 | GO:0045937 | positive regulation of phosphorus metabolic process(GO:0010562) positive regulation of phosphate metabolic process(GO:0045937) |
0.1 | 0.1 | GO:0048167 | regulation of synaptic plasticity(GO:0048167) |
0.1 | 0.5 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 1.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 1.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.4 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.1 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 1.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.8 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.1 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.2 | GO:1903979 | regulation of microglial cell activation(GO:1903978) negative regulation of microglial cell activation(GO:1903979) |
0.1 | 1.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.6 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 0.4 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.3 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) negative regulation of mitotic cell cycle DNA replication(GO:1903464) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 0.4 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.4 | GO:0021825 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
0.1 | 1.7 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.1 | 1.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.3 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.1 | 0.2 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 4.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.8 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.1 | 1.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 6.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 2.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.2 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 1.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 3.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.1 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.7 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.6 | GO:0002353 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.1 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.1 | 0.7 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.1 | 0.4 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 1.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.1 | 0.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.6 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 1.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.6 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 0.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.1 | 0.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.1 | 1.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.1 | 0.3 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.1 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 2.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.1 | 1.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 1.8 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.3 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.1 | 0.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.2 | GO:1903923 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.1 | 0.3 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.1 | 0.1 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.1 | 1.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.2 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.3 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.1 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.1 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 1.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.1 | 0.2 | GO:0002396 | MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
0.1 | 1.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.4 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.2 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 0.1 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.1 | 0.2 | GO:0070631 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.1 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.5 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.5 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 0.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0070997 | neuron death(GO:0070997) |
0.1 | 7.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.2 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 0.3 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.6 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 2.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 3.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 1.3 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.3 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.1 | 0.4 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.2 | GO:0034059 | response to anoxia(GO:0034059) |
0.1 | 0.5 | GO:0042092 | type 2 immune response(GO:0042092) |
0.1 | 1.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 1.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 1.5 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.1 | GO:0031247 | actin rod assembly(GO:0031247) |
0.1 | 0.5 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 0.2 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 1.7 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.3 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 2.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 0.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.1 | 0.3 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.1 | 0.3 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.1 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.1 | 0.4 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.1 | 1.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.3 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.1 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.5 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.1 | 1.0 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 1.1 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.9 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.1 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.1 | 0.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.2 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.1 | 0.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.9 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.7 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.1 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.1 | 0.1 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.1 | 0.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.1 | 0.3 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 1.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 0.2 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 0.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 1.0 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 1.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.4 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.6 | GO:0008104 | protein localization(GO:0008104) |
0.1 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.3 | GO:0045428 | regulation of nitric oxide biosynthetic process(GO:0045428) |
0.1 | 3.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.1 | 0.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.1 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |